The role of polymorphisms in the genes of the hemostasis system and the folate-methionine cycle in the development of recurrent pregnancy loss
Early Pregnancy Loss
Recurrent miscarriage
DOI:
10.17816/jowd112514
Publication Date:
2023-09-28T18:14:27Z
AUTHORS (5)
ABSTRACT
BACKGROUND:Recurrent pregnancy loss is a serious clinical problem that complicates about 2% of pregnancies. There evidence thrombophilia and disorders folate-methionine metabolism may cause recurrent loss.
 AIM:The aim this study was to evaluate the contribution polymorphic variants genes hemostasis system cycle in women with MATERIALS AND METHODS:Clinical examination 406 pregnant divided into two groups carried out. The main group consisted 206 or more losses known up 12 weeks pregnancy; control included 200 apparently healthy history live births, no spontaneous induced abortions, infertility, endometriosis. All patients underwent molecular genetic single nucleotide polymorphisms performed by real-time polymerase chain reaction.
 RESULTS:We studied eight involved four cycle. An association presence alternative such as 1565C (rs5918) theITGB3integrin beta-3 gene A66G (rs1801394) theMTRRmethionine synthase reductase development found. frequency their occurrence 29.1 77.7% vs. 12.0 49.0% group, respectively (p 0.01). combined carriage theITGB3gene theMTRRgene diagnosed often than amounted 47 (22.8%) (6.0%) cases ( = 5.047;p 0.01; odds ratio 3.631; 95% confidence interval 2.3749.034). We have thus developed three-locus model synergetic action allelic above early [10976 GA (rs6046) theF7, 455 (rs1800790) theFGB, 1565 TC theITGB3] reproducibility 8/10, sensitivity 65.6%, specificity 68.8% 15.7415,p 0.0001; 3.341, 1.8246.118).
 CONCLUSIONS:This allows for confirming hypothesis status theITGB3andMTRRgenes three polymorphisms: rs6046 rs1800790 rs5918 theITGB3may be used predictors development.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (36)
CITATIONS (1)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....